Clinical Trials Directory

Trials / Conditions / Ann Arbor Stage IV Non-Hodgkin Lymphoma

Ann Arbor Stage IV Non-Hodgkin Lymphoma

6 registered clinical trials studyying Ann Arbor Stage IV Non-Hodgkin Lymphoma.

StatusTrialSponsorPhase
TerminatedSerial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
NCT03878524
OHSU Knight Cancer InstitutePhase 1
CompletedSamotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or H
NCT03213678
National Cancer Institute (NCI)Phase 2
CompletedTazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or
NCT03213665
National Cancer Institute (NCI)Phase 2
Active Not RecruitingTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanc
NCT03155620
National Cancer Institute (NCI)Phase 2
Active Not RecruitingVorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage
NCT00972478
National Cancer Institute (NCI)Phase 1 / Phase 2
Active Not RecruitingVeliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectabl
NCT00740805
National Cancer Institute (NCI)Phase 1